Ventrus Biosciences, Inc. President, Chairman & CEO to Ring the NASDAQ Stock Market Closing Bell
ADVISORY, May 18, 2011 (GLOBE NEWSWIRE) -- What: Ventrus Biosciences (VTUS), a specialty pharmaceutical company focusing in late-stage clinical development of gastrointestinal products, will visit the NASDAQ MarketSite in New York City's Times Square.